ADBiotech Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-3,304	-7,952	-2,863	2,696	-2,664
Depreciation & Amortization	957.02	1,025	1,134	725.66	651.6
Loss (Gain) From Sale of Assets	-	4.43	-	-	-1.82
Asset Writedown & Restructuring Costs	1,503	421.96	2,590	45.21	-
Loss (Gain) From Sale of Investments	650.25	4,263	-3,023	-390.47	24.16
Stock-Based Compensation	81.52	97.85	80.28	172.9	74.91
Provision & Write-off of Bad Debts	-163.62	156.41	-389.33	391.19	418.3
Other Operating Activities	-2,524	-990.26	-1,523	-7,354	790.4
Change in Accounts Receivable	1,139	-1,338	660.74	1,197	-2,135
Change in Inventory	105.25	-183.68	450.38	-1,071	-232.37
Change in Accounts Payable	37.9	1,390	-129.32	-730.49	631.69
Change in Unearned Revenue	-	-	-49.75	-	-
Change in Other Net Operating Assets	198.64	-986.07	3,378	-4,274	257.49
Operating Cash Flow	-1,319	-4,092	314.93	-8,592	-2,186
Capital Expenditures	-15,811	-193.38	-239.9	-726.72	-3,561
Sale of Property, Plant & Equipment	0.32	10.23	-	-	1.82
Cash Acquisitions	-	-	-1,381	-	-
Sale (Purchase) of Intangibles	-	-	-50	-	-
Investment in Securities	-6,254	1,322	4,094	-1,106	-1,198
Other Investing Activities	-20.33	102.61	-15.86	34.09	256.9
Investing Cash Flow	-26,004	1,241	2,407	-2,199	-4,500
Short-Term Debt Issued	6,000	1,100	1,560	2,057	1,000
Long-Term Debt Issued	16,700	5,500	900	-	4,500
Total Debt Issued	22,700	6,600	2,460	2,057	5,500
Long-Term Debt Repaid	-1,708	-6,107	-3,345	-793.7	-252.3
Net Debt Issued (Repaid)	20,992	493.24	-885.19	1,263	5,248
Issuance of Common Stock	9,812	-	-	9,928	198.5
Other Financing Activities	-183.44	-8.83	-	-396.88	-12.77
Financing Cash Flow	30,620	484.41	-885.19	10,794	5,433
Foreign Exchange Rate Adjustments	-22.65	-10.24	-1.56	-19.03	9.41
Net Cash Flow	3,275	-2,376	1,836	-16.18	-1,243
Free Cash Flow	-17,130	-4,285	75.03	-9,319	-5,747
Free Cash Flow Margin	-132.82%	-38.48%	0.72%	-87.66%	-48.54%
Free Cash Flow Per Share	-1425.77	-468.82	8.21	-924.41	-747.71
Cash Interest Paid	329.13	355.34	333.45	158.75	137.52
Cash Income Tax Paid	-0.18	-0.92	5.51	21.24	-13.28
Levered Free Cash Flow	-10,704	-612.42	-1,259	-3,247	-4,961
Unlevered Free Cash Flow	-9,569	-186.13	-992.12	-3,170	-4,880
Change in Working Capital	1,481	-1,119	4,310	-4,879	-1,479

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.